Trial & Ticker

Biotech Catalyst Intelligence

Fintech

Tech

Finance

Hi Product Hunt,

I’m Tejas. For more than seven years, I worked as a quantitative researcher developing strategies around small and mid-cap biotech companies.

Clinical-trial results can transform these companies overnight. But understanding which trials matter requires connecting trial records, financial filings, drug approvals, company pipelines, competitive landscape and market activity.

Existing catalyst calendars are good at answering when an event may happen. I wanted to help answer a different question:

How much could this event matter to the stock, and why?

That became Trial & Ticker.

It ranks upcoming clinical-trial catalysts and explains the individual factors behind every score. It does not provide buy or sell recommendations. The goal is to make serious biotech research easier to understand.

The entire product is free, with no signup or credit card.

I built it independently on a very small budget. I would especially value feedback on whether the scores are easy to understand and what would make you trust the analysis enough to return.

Thank you for taking a look.

Gallery Content

1. Landing page with the Trial & Ticker name and tagline.

2. Dashboard showing ranked upcoming company catalysts.

3. Expanded company analysis with individual scoring factors.

4. “How scores work” view showing the explainability.

5. Backtest or research article demonstrating accountability.